Company Filing History:
Years Active: 2022
Title: **The Innovative Contributions of Inventor Kyung-Hee Kim**
Introduction
Kyung-Hee Kim is a prolific inventor based in Daegu, South Korea, known for her contributions to pharmaceuticals. With a focused dedication to innovation, she has developed a groundbreaking patent that addresses significant health issues.
Latest Patents
Kyung-Hee Kim holds a patent for a compound known as 2-cyanopyrimidin-4-yl carbamate or urea derivative or its pharmaceutically acceptable salt. This invention also includes a pharmaceutical composition that utilizes the same compound. The significance of this patent lies in its ability to selectively inhibit cathepsin K, making it a promising candidate for the prevention and treatment of osteoporosis.
Career Highlights
Currently, Kyung-Hee Kim is affiliated with Hanlim Pharmaceutical Co., Ltd., where she continues to engage in innovative research and development. Her work significantly contributes to advancements in pharmaceutical science, emphasizing the importance of finding effective treatments for common ailments such as osteoporosis.
Collaborations
Throughout her career, Kyung-Hee Kim has collaborated with esteemed colleagues, including Jung-Wook Chin and Ji-Hoon Lee. This collaborative spirit enhances the research environment and facilitates the exchange of ideas, fostering further innovations in the field.
Conclusion
Kyung-Hee Kim exemplifies the spirit of innovation within the pharmaceutical industry. Her patent highlights the potential of her inventions to impact public health positively. As she continues her work at Hanlim Pharmaceutical Co., Ltd., the contributions of this inventor are sure to inspire future developments in medicine.